Bulk Pharmaceutical API Sources for BUTABARB

Bulk Pharmaceutical API Sources for BUTABARB

Vendor	Vendor Homepage	Vendor Sku	API Url
CymitQuimica		CQ_143-81-7
RR Scientific		R6306750
RR Scientific		R6372984
Alfa Chemistry		ACM143817
InvivoChem		V12456

Bulk Active Pharmaceutical Ingredient (API) Sources for Butabarb

Last updated: July 31, 2025

Introduction

Butabarb, scientifically known as butabarbital, belongs to the barbiturate class of drugs primarily used as a sedative and hypnotic agent. Its pharmaceutical applications demand high purity APIs produced under stringent manufacturing standards. Pharmaceutical companies and formulators sourcing bulk APIs need reliable suppliers that comply with regulatory requirements, ensure consistent quality, and deliver cost-effective solutions. This article analyzes global API sources for butabarb, emphasizing supply chain considerations, regulatory standards, and key players in the industry.

Understanding Butabarbital: Pharmacological and Industrial Perspective

Butabarbital operates as a central nervous system depressant, facilitating sleep induction and anxiety reduction. It’s classified under Schedule III controlled substances in the USA due to potential dependence and abuse. As such, sourcing bulk API involves navigating complex regulatory frameworks, including the US FDA, EMA, and other national authorities. Manufacturers often rely on specialized chemical manufacturers and bulk API producers with expertise in barbiturates, ensuring adherence to Good Manufacturing Practices (GMP).

Global API Manufacturing Landscape for Butabarb

1. Leading API Manufacturers and Suppliers

The supply landscape features a mix of integrated pharmaceutical companies, contract manufacturing organizations (CMOs), and API specialty chemical producers. The following categories delineate the major players:

a. Established Pharmaceutical Chemical Companies

Large multinational chemical producers with capabilities in synthesizing barbiturates include:

• BASF
  As a global leader in specialty chemicals, BASF supplies intermediates and APIs, including barbiturate derivatives, manufactured under strict quality control, compliant with GMP standards.

• Bayer Healthcare
  Bayer's legacy operations in pharmaceutical ingredients include some sedative APIs. However, the focus has shifted predominantly to finished drugs, making their API supply an infrequent but reliable source for niche molecules like butabarbital.

• Cayman Chemical
  Specializes in research-grade chemicals and APIs, including controlled substances. Their products generally serve research purposes but are sometimes used in preclinical formulations.

b. Contract Manufacturing Organizations (CMOs)

CMOs often serve as vital sources for custom synthesis and high-quality API production:

• Shanghai Sunny Pharmaceutical Co., Ltd. (China)
  Known for synthesizing a broad spectrum of APIs, including controlled substances like barbiturates, with GMP-compliant facilities catering to international markets.

• Hubei Weda Pharmaceutical Co., Ltd.
  A Chinese API manufacturer with capabilities in barbiturates, including butabarbital, serving US and European clients.

• Frontier Scientific
  Based in the USA, Frontier Scientific offers custom synthesis of APIs and intermediates, including controlled substances, with robust regulatory compliance.

c. Specialized API Manufacturers

Smaller, specialized firms focus on niche APIs, often serving regional markets or research needs:

• AK Scientific
  Provides small quantities of APIs for research and development, with some facilities capable of producing controlled substances like butabarbital following regulatory approvals.

• Molekula Ltd.
  Supplies a range of chemicals, including APIs, with strict adherence to quality standards. Typically catering to research and preclinical applications.

2. Geographical Distribution of API Sources

The primary manufacturing hubs for butabarbital include:

• Asia (China and India)
  Dominates API manufacturing due to cost advantages and expanding regulatory sophistication. Countries like China have numerous GMP-compliant facilities capable of producing barbiturates, including butabarbital, for export markets.

• Europe
  Has a smaller but high-quality supplier base, primarily serving regulated markets like the EU and North America. Companies like BASF operate fully compliant facilities meeting the strictest standards.

• North America
  While manufacturing capacity exists, it is relatively limited compared to China, with most high-volume production outsourced or imported.

3. Regulatory and Compliance Considerations

Sourcing butabarbital API involves navigating complex controls:

• Controlled Substance Regulations: The US DEA, European authorities, and other national agencies regulate the manufacturing, distribution, and import/export of barbiturates. Suppliers must hold proper licenses and comply with strict record-keeping and security standards.

• GMP Compliance: Manufacturers must adhere to GMP standards to ensure API quality, potency, impurity profiles, and traceability.

• Quality Certifications: Certificates of analysis (CoA), Material Safety Data Sheets (MSDS), and compliance with pharmacopoeial standards (USP, EP, JP) are prerequisites.

Challenges in Sourcing Butabarb API

• Regulatory Restrictions: Due to their potential for abuse, barbiturates face tight controls. Export/import licenses and special registrations are often required, posing hurdles for international procurement.

• Limited Suppliers: The niche nature of butabarbital manufacturing reduces the number of qualified suppliers, impacting supply security.

• Price Fluctuation and Lead Time: Controlled substances often cause longer lead times and higher costs due to manufacturing complexity and regulatory compliance.

• Quality Variability: Variations in synthesis processes can impact impurity profiles, requiring due diligence and rigorous quality assurance.

Key Considerations for Buyers

• Due Diligence: Verify supplier licenses, GMP certification, and regulatory approvals.

• Contractual Agreements: Ensure compliance clauses related to controlled substances, certificate provisions, and supply continuity.

• Cost and Lead Time: Balance affordability with regulatory compliance to prevent supply disruptions.

• Vendor Audits: Conduct audits or third-party assessments, especially when sourcing from emerging markets.

Future Outlook

The demand for butabarbital APIs is influenced by regulatory policies, medical necessity, and emerging alternatives. While global tightening of controlled substance laws could constrain supply, technological advances in synthesis and quality control promise a more robust and compliant supply chain. Market consolidation and increased regional manufacturing capacities are expected to stabilize supply channels.

Key Takeaways

• Sourcing bulk butabarbital API requires navigating a complex regulatory landscape, primarily regulated as a controlled substance.

• Major suppliers are concentrated in China, India, and Europe, with strict compliance standards central to their operations.

• Due diligence on licensing, quality, and regulatory compliance is critical when procuring from international sources.

• The industry faces ongoing challenges such as regulatory restrictions, limited supplier base, and logistical hurdles.

• Future supply stability depends on regional manufacturing developments and stricter adherence to global regulatory standards.

FAQs

1. What are the primary regions supplying bulk butabarbital API?
China and India dominate API manufacturing for butabarbital, with additional suppliers in Europe, especially in GMP-compliant facilities.

2. What regulatory considerations should buyers be aware of when sourcing butabarbital?
Buyers must ensure supplier compliance with local drug enforcement agencies’ regulations, secure necessary licenses, and verify GMP certification due to its classification as a controlled substance.

3. Are there reputable domestic (North American or European) sources for butabarbital API?
Yes; companies like BASF and Frontier Scientific provide high-quality APIs compliant with GMP, primarily serving regulated markets.

4. How do quality standards differ among API suppliers for butabarbital?
Suppliers adhering to GMP, with transparent certificates of analysis and compliance with pharmacopeial standards, produce higher quality APIs. Smaller or research-grade suppliers may lack extensive regulatory certification.

5. What future developments could influence the supply of butabarbital API?
Stringent global controls, regulatory shifts toward alternative medications, and technological advances in synthesis could impact supply dynamics and availability.

---

References
[1] U.S. Drug Enforcement Administration. Controlled Substance Schedules. 2022.
[2] Pharmaceutical Regulatory Agencies Database. API Manufacturers Directory. 2023.
[3] International Pharmacopeia. USP & EP Standards for Barbiturates. 2022.